ACI Medical

Executive Summary

ACI Medical, a privately held medical device company based in San Diego, has been dedicated to improving peripheral circulation since 2001. Their flagship product, ArtAssist®, is a portable intermittent pneumatic compression device designed for home use to treat conditions such as peripheral artery disease and edema. The device features an easy-to-use controller and inflatable cuffs that patients can apply themselves, promoting compliance and convenience. With over two decades of market presence, ACI Medical has established a niche in the vascular therapy space, though the company remains relatively small with limited public visibility. The aging population and rising prevalence of cardiovascular diseases present a growing addressable market for ArtAssist®, which offers a non-invasive alternative to more aggressive interventions. However, competition from larger players and the need for robust clinical evidence to support reimbursement and physician adoption remain key challenges. The company's private status and lack of disclosed funding rounds suggest it may be self-sustaining or financed through debt or private investors, potentially limiting its ability to scale rapidly without a strategic partner or capital infusion.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance for Expanded Indication in Chronic Venous Insufficiency70% success
• H1 2027Publication of Pivotal Clinical Trial Results for ArtAssist® in Critical Limb Ischemia50% success
• Q3 2026Distribution Agreement with National Home Healthcare Provider40% success